NSE filing, NSE: RKEC. Summary written from the filing by ALFA Finder's alert engine.
RKEC Projects Ltd: key numbers
- Share price
- ₹17.50
- Market cap
- ₹45.19 Cr
- P/E (TTM)
- -0.8×Sector 31.7×
- Promoter holding
- 57.74%-8.77% QoQ
- FII holding
- 0.10%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from RKEC Projects Ltd
All →RKEC Projects Annual General Meeting
RKEC Projects Limited held its 21st Annual General Meeting on September 30, 2026. The meeting covered the adoption of financial statements and the re-appointment of directors.
RKEC Projects Annual Report
RKEC Projects Limited has filed its 21st Annual Report. The document includes the AGM notice and financial statements for the company.
RKEC Projects Annual General Meeting
RKEC Projects Limited has issued a notice for its Twenty-First Annual General Meeting scheduled for September 30, 2026. Shareholders will consider and adopt the financial statements.
RKEC Projects Debt & Borrowing: ₹68.42 Cr
RKEC Projects Limited disclosed a default on loan repayments, with an outstanding default amount of ₹68.42 Crore as of July 31, 2026.
- Value
- ₹68.42 Cr
RKEC Projects Q4 FY26 Results: Net Loss of ₹41.5 Cr
RKEC Projects Ltd reported revenue from operations of ₹40.4 Cr (-71.4% YoY) and a net loss of ₹41.5 Cr for Q4 FY26.
- Key figure
- Net loss ₹41.5 Cr
RKEC Projects Board Meeting Date
RKEC Projects Limited has rescheduled its board meeting to 10-Aug-2026 to approve the yearly audited financial results, originally scheduled for 7-Aug-2026.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.